2 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Malignant Peritoneal Mesothelioma, Advanced: new trials by email Literature Review of Malignant Peritoneal Mesothelioma, Advanced trials Research Report on Malignant Peritoneal Mesothelioma, Advanced
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CT-95 in Advanced Cancers Associated With Mesothelin Expression CT-95 - Mesothelin-Expressing Tumors, Epithelial Ovarian Cancer | Phase 1 | Recruiting | Context Therapeutics Inc. | 70 | 2025-03-31 | 2026-06-12 |
| Sintilimab, Bevacizumab, Pemetrexed, and Cisplatin for Unresectable MPeM Sintilimab, Bevacizumab , Pemetrexed , Cisplatin - Malignant Peritoneal Mesothelioma, Advanced | Phase 2 | Recruiting | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 28 | 2024-01-31 | 2024-08-07 |
Carcinoma, Ovarian Epithelial (1) · Colorectal Neoplasms (1) · Mesothelioma, Malignant (1) · Neoplasm Metastasis (1) · Neoplasms (1)
Adenoma (1) · Adnexal Diseases (1) · Carcinoma (1) · Colonic Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1)
Bevacizumab (1) · Cisplatin (1) · Pemetrexed (1) · sintilimab (1)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1) · Context Therapeutics Inc. (1)
China (1) · United States (1)
Karen Chagin, MD (1) · Yongkun Sun, Doctor (1)